Ozturk Cengizhan, Guttman Michael, McVeigh Elliot R, Lederman Robert J
Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Top Magn Reson Imaging. 2005 Oct;16(5):369-81. doi: 10.1097/00002142-200510000-00004.
Magnetic resonance imaging (MRI), which provides superior soft-tissue imaging and no known harmful effects, has the potential as an alternative modality to guide various medical interventions. This review will focus on MR-guided endovascular interventions and present its current state and future outlook. In the first technical part, enabling technologies such as developments in fast imaging, catheter devices, and visualization techniques are examined. This is followed by a clinical survey that includes proof-of-concept procedures in animals and initial experience in human subjects. In preclinical experiments, MRI has already proven to be valuable. For example, MRI has been used to guide and track targeted cell delivery into or around myocardial infarctions, to guide atrial septal puncture, and to guide the connection of portal and systemic venous circulations. Several investigational MR-guided procedures have already been reported in patients, such as MR-guided cardiac catheterization, invasive imaging of peripheral artery atheromata, selective intraarterial MR angiography, and preliminary angioplasty and stent placement. In addition, MR-assisted transjugular intrahepatic portosystemic shunt procedures in patients have been shown in a novel hybrid double-doughnut x-ray/MRI system. Numerous additional investigational human MR-guided endovascular procedures are now underway in several medical centers around the world. There are also significant hurdles: availability of clinical-grade devices, device-related safety issues, challenges to patient monitoring, and acoustic noise during imaging. The potential of endovascular interventional MRI is great because as a single modality, it combines 3-dimensional anatomic imaging, device localization, hemodynamics, tissue composition, and function.
磁共振成像(MRI)能够提供出色的软组织成像,且无已知有害影响,有潜力成为指导各种医学干预的替代方式。本综述将聚焦于磁共振引导的血管内介入治疗,并介绍其现状和未来展望。在第一部分技术内容中,将探讨诸如快速成像、导管设备及可视化技术等方面的 enabling 技术发展情况。接下来是一项临床调查,其中包括动物实验中的概念验证程序以及人体受试者的初步经验。在临床前实验中,MRI 已被证明具有重要价值。例如,MRI 已被用于引导和追踪靶向细胞输送至心肌梗死区域或其周边,引导房间隔穿刺,以及引导门静脉和体静脉循环的连接。已有多项针对患者的磁共振引导程序的研究报告,如磁共振引导的心脏导管插入术、外周动脉粥样斑块的有创成像、选择性动脉内磁共振血管造影以及初步的血管成形术和支架置入术。此外,在一种新型的双环形 X 射线/磁共振成像混合系统中展示了针对患者的磁共振辅助经颈静脉肝内门体分流术。目前,世界各地的多个医疗中心正在开展许多其他针对人体的磁共振引导血管内介入程序研究。然而,也存在重大障碍:临床级设备的可用性、与设备相关的安全问题、患者监测方面的挑战以及成像过程中的声学噪声。血管内介入磁共振成像的潜力巨大,因为作为单一模式,它结合了三维解剖成像、设备定位、血流动力学、组织成分和功能。